497 related articles for article (PubMed ID: 35929637)
1. Transthyretin cardiac amyloidosis.
Porcari A; Fontana M; Gillmore JD
Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
[TBL] [Abstract][Full Text] [Related]
2. Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy.
Fontana M; Porcari A; Hawkins PN
Glob Heart; 2023; 18(1):63. PubMed ID: 38028963
[TBL] [Abstract][Full Text] [Related]
3. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy.
Porcari A; Sinagra G; Gillmore JD; Fontana M; Hawkins PN
Eur J Intern Med; 2024 May; 123():29-36. PubMed ID: 38184468
[TBL] [Abstract][Full Text] [Related]
5. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.
Lyng CS; Gude E; Hodt A; Knudsen EC
Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
Ruberg FL; Maurer MS
JAMA; 2024 Mar; 331(9):778-791. PubMed ID: 38441582
[TBL] [Abstract][Full Text] [Related]
7. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
Ruberg FL; Grogan M; Hanna M; Kelly JW; Maurer MS
J Am Coll Cardiol; 2019 Jun; 73(22):2872-2891. PubMed ID: 31171094
[TBL] [Abstract][Full Text] [Related]
8. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
Smiley DA; Rodriguez CM; Maurer MS
Cardiol Clin; 2022 Nov; 40(4):541-558. PubMed ID: 36210137
[TBL] [Abstract][Full Text] [Related]
9. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
Razvi Y; Ioannou A; Patel RK; Chacko L; Karia N; Riefolo M; Porcari A; Rauf MU; Starr N; Ganesananthan S; Blakeney I; Kaza N; Filisetti S; Bolhuis RE; Rowczenio D; Gilbertson J; Hutt D; Mahmood S; Lachmann HJ; Wechalekar AD; Kotecha T; Knight DS; Coghlan JG; Petrie A; Whelan CJ; Venneri L; Martinez-Naharro A; Hawkins P; Fontana M; Gillmore JD
Eur J Heart Fail; 2024 Feb; 26(2):383-393. PubMed ID: 37953725
[TBL] [Abstract][Full Text] [Related]
10. Native T1 and Extracellular Volume in Transthyretin Amyloidosis.
Martinez-Naharro A; Kotecha T; Norrington K; Boldrini M; Rezk T; Quarta C; Treibel TA; Whelan CJ; Knight DS; Kellman P; Ruberg FL; Gillmore JD; Moon JC; Hawkins PN; Fontana M
JACC Cardiovasc Imaging; 2019 May; 12(5):810-819. PubMed ID: 29550324
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.
Hänselmann A; Berliner D; Bauersachs J; Bavendiek U
Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
[TBL] [Abstract][Full Text] [Related]
14. Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
Löfbacka V; Suhr OB; Pilebro B; Wixner J; Sundström T; Lindmark K; Anan I; Lindqvist P
Clin Physiol Funct Imaging; 2021 Sep; 41(5):408-416. PubMed ID: 34033209
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin: Its function and amyloid formation.
Ueda M
Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
[TBL] [Abstract][Full Text] [Related]
16. Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
Bhuiyan T; Helmke S; Patel AR; Ruberg FL; Packman J; Cheung K; Grogan D; Maurer MS
Circ Heart Fail; 2011 Mar; 4(2):121-8. PubMed ID: 21191093
[TBL] [Abstract][Full Text] [Related]
17. Cardiac amyloidosis: An underdiagnosed/underappreciated disease.
Manolis AS; Manolis AA; Manolis TA; Melita H
Eur J Intern Med; 2019 Sep; 67():1-13. PubMed ID: 31375251
[TBL] [Abstract][Full Text] [Related]
18. Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy.
Alwan L; Benz DC; Cuddy SAM; Dobner S; Shiri I; Caobelli F; Bernhard B; Stämpfli SF; Eberli F; Reyes M; Kwong RY; Falk RH; Dorbala S; Gräni C
JACC Cardiovasc Imaging; 2024 Feb; 17(2):195-211. PubMed ID: 38099914
[TBL] [Abstract][Full Text] [Related]
19. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Edema and Prognosis in Amyloidosis.
Kotecha T; Martinez-Naharro A; Treibel TA; Francis R; Nordin S; Abdel-Gadir A; Knight DS; Zumbo G; Rosmini S; Maestrini V; Bulluck H; Rakhit RD; Wechalekar AD; Gilbertson J; Sheppard MN; Kellman P; Gillmore JD; Moon JC; Hawkins PN; Fontana M
J Am Coll Cardiol; 2018 Jun; 71(25):2919-2931. PubMed ID: 29929616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
